期刊文献+

对氧磷酶1192Gln/Arg和对氧磷酶2311Cys/Ser多态性与2型糖尿病合并大血管病变的相关性 被引量:1

The Association of Paraoxonase-1 192 Gln/Arg and Paraoxonase-2 311 Cys/Ser Gene Polymorphisms with Macrovascular Disease in Type 2 Diabetes Mellitus Patients
下载PDF
导出
摘要 目的探讨对氧磷酶1基因192 Gln/Arg和对氧磷酶2基因311 Cys/Ser多态性与山东青岛地区2型糖尿病患者合并大血管病变的关系。方法通过抽提基因组DNA并应用聚合酶链反应检测对氧磷酶1 192 Gln/Arg和对氧磷酶2 311 Cys/Ser多态性在2型糖尿病合并大血管病变组、单纯2型糖尿病组以及正常对照组的基因频率。联合分析两种基因变异在2型糖尿病合并大血管病变的发病中有无协同效应。结果山东青岛地区人群存在对氧磷酶1 192 Gln/Arg和对氧磷酶2 311 Cys/Ser多态性。2型糖尿病合并大血管病变组与单纯2型糖尿病组和正常对照组比较对氧磷酶1的3种基因型(QQ、QR、RR)的构成比差异无显著性,而对氧磷酶2的3种基因型(CC、CS、SS)的构成比差异有显著性(P〈0.05或P〈0.01),S等位基因频率较其他两组显著增高(P〈0.05或P〈0.01)。联合分析发现对氧磷酶2 311 S等位基因是2型糖尿病合并大血管病变的独立危险因素,当对氧磷酶2 311 S等位基因与对氧磷酶1 192 R等位基因并存时,患2型糖尿病合并大血管病变的相对危险度明显增加(OR=49.494,95%CI为0.907-2701.872)。结论在山东青岛地区人群中,对氧磷酶2 311 Cys/Ser多态性与2型糖尿病合并大血管病变具有相关性,其S等位基因可能是该地区2型糖尿病合并大血管病变的危险因素之一。当同时检测出对氧磷酶1 192 R等位基因时对2型糖尿病合并大血管病变更具有预测或诊断价值。 Aim To investigate the association between paraoxonase-2 gene 311 Cys/Ser polymorphism and macrovaseular disease in combination with paraoxonase-1 gene 192 GlrdArg polymorphisan in type 2. diabetes mellitus patients. Methods A ease-control study of 272 Chinese subjects was performet. Genomie DNA was extracted from the subjects' peripheral blood leukocytes. The paraoxonase-1 gene 192 GlrdArg and paraoxonase-2 gene 311 Cys/Ser polymorphisms were determined by PCR analysis. In addition, the association was investigated between paraoxonase-2 gene 311 Cys/Ser polymorphism and maerovaseular disease in combination wifla paraoxonase- 1 gene 192 GlrdArg polymorplfism in control group and type 2 diabetes mellitus complicated witli macrovascular disease group. Results Paraoxonase-1 gene 192 Gln/Arg and paraoxonase-2 gene 311 Cys/Ser polymorphisms were detected in population of Qingdao. The genetype distribution (QQ, QR and RR) of paraoxonase-1 gene 192 Gln/Arg polymorphism showed no significant differences between type 2 diabetes mellitus complicated with macrovascular disease group and the other two groups(type 2 diabetes mellitus group & healthy subjects). But the genetype distribution (CC,'CS and SS ) of paraoxonase-2 gene 311 Cys/Ser polymorphism showed significant differences between type 2 diabetes mellitus complicated with maerovascular disease group and the other two groups, the former had a significantly lfigher S allele frequency ( P 〈 0.05 or P 〈 0.01 ). The linkage analysis of pmaoxonase-2 gene 311 Cys/Ser and paraoxonase-1 gene 192 Gln/Arg gene polymorphisms further emphasized that paraoxonase-2 gene 311 S allele was an independent risk factor leading to type 2 diabetes mellitus complicated with maerovascular disease. Wben both of the paraoxonase-2 gene 311 S allele and the paraoxonase-1 gene 192 R allele existed, tire OR of paraoxonase-2 gene 311 S allele for type 2 diabetes nreUitus complicated with maerovascular disease was significandy higher (OR= 49.494, 95%CI: 0.907- 2 701.872). Condusions The paraoxonase-2 gene 311 Cys/Ser polymorphism is associated with type 2 diabetes meUitus complicated with macrovasctdar disease in Qingdao's population. S allele may be a risk factor for type 2 diabetes meUitus complicated with macrovascular disease. Meanwhile, detecting the paraoxonase-I gene 192 R allele may provide a more precise method to predict or diagnose type 2 diabetes meUitus complicated with macrovascular disease.
出处 《中国动脉硬化杂志》 CAS CSCD 2007年第9期703-707,共5页 Chinese Journal of Arteriosclerosis
关键词 内科学 对氧磷酶1 对氧磷酶2 2型糖尿病 基因多态性 大血管病变 Paraoxonase-1 Paraoxonase-2 Type 2 Diabetes Mellitus Gene Polymorphism Macrovascular Disease Allele Frequency
  • 相关文献

参考文献4

二级参考文献56

  • 1Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol, 2004, 11 (5): 412-419.
  • 2Deakin SP, James RW. Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. Clin Sci, 2004, 107 (5): 435-447.
  • 3Wang X, Huang J, Fan Z, Su S, Zhao J, Shen Y. Genetic and environmental factors associated with plasma paraoxonase activity in healthy Chinese. Int J Mol Med, 2004, 13 (3): 445-450.
  • 4Shih DM, Xia YR, Miller E, Castellani LW, Subbanagounder G, Cheroutre H. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem, 2000, 275 (23): 17 527-535.
  • 5Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation, 2002, 106 (4): 484-490.
  • 6Aviram M, Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med, 2004, 37 (9): 1 304-316.
  • 7Mackness B, Durrington DN, Mackness MI. Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation. Lancet, 1999, 353 (9151): 468-469.
  • 8La Du BN. Future studies of low-activity pon1 phenotype subjects may reveal how pon1 protects against cardiovascular disease. Arterioscler Thromb Vasc Biol, 2003, 23 (8): 1 317-318.
  • 9Suehiro T, Nakamura T, Inoue M, Shiinoki T, Ikeda Y, Kumon Y. A polymorphisms upstream from the human paraoxonase gene and its association with PON1 expression. Atherosclerosis, 2000, 150 (2): 295-298.
  • 10Leviev I, James RW. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol, 2000, 20 (2): 516-521.

共引文献33030

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部